Type Public company Headquarters Mumbai Founded 1924 | Products Medicines and vaccines Number of employees 3,500 Parent organization GlaxoSmithKline | |
 | ||
Traded as BSE: 500660
NSE: GSKCONS Industry Pharmaceuticals & healthcare Key people Dr. Hasit Joshipura, Managing Director Revenue ₹23.76 billion (US$350 million) (2011) Stock price GLAXO (NSE) ₹ 2,693.25 -12.65 (-0.47%)14 Mar, 3:30 PM IST - Disclaimer Subsidiaries Samgir investments Ltd, Glindia investments Ltd, Biddle Sawyer Limited, S B Pharmaceutical Services | ||
GlaxoSmithKline Pharmaceuticals Ltd (BSE: 500660 NSE: GSKCONS) is an Indian subsidiary of GlaxoSmithKline plc, one of the world's leading research based pharmaceutical and healthcare companies. It is one of the oldest pharmaceuticals companies in India. It product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer and others.
History
It was founded 13 November 1924 in India under the name of H.J.Foster & Co. Limited as an Agency House for distributing Baby Food Glaxo, Joseph Nathan & Co. In 1950, It changed its name to Glaxo Laboratories (I) Ltd.